The format of the patient-focused listening sessions hosted by the Centers for Medicare and Medicaid Services on the drugs chosen for Medicare price negotiation may ultimately have undercut their usefulness, resulting in relatively low overall turnout and repetitive presentations by the same few organizations.
Although CMS projected that approximately 20 speakers would participate in each of the 10 meetings, which were held via Zoom...







